Radiotherapy of experimental lung tumors in the presence and absence of a radioprotective drug, S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721).
D000236:Adenoma / Q000139:chemically induced / Q000401:mortality / Q000532:radiotherapy*; D000818:Animals; D004307:Dose-Response Relationship, Radiation; D008175:Lung Neoplasms / Q000139:chemically induced / Q000401:mortality / Q000532:radiotherapy*; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000401:mortality / Q000532:radiotherapy; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use*; D011437:Propylamines / Q000627:therapeutic use; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D011855:Radiodermatitis / Q000517:prevention & control; D013997:Time Factors; D014520:Urethane
D009946:Organothiophosphorus Compounds; D011437:Propylamines; D011837:Radiation-Protective Agents; D014520:Urethane